Table 1. Evaluation of clinical and laboratory features of the patients by groups.
*One-way analysis of variance: posthoc = Scheffe alpha test.
**Crosstabs: chi-square test.
Note: data are presented as mean ± SD for age and as N (%) for other data.
NAS, nonalcoholic hepatosteatosis; NASH, nonalcoholic steatohepatitis
| Control (35) | NAS (73) | NASH (28) | p-Value | |
| Age, years | 10.74±3.38 | 11.68±3.96 | 11.75±3.19 | 0.413* |
| Gender | ||||
| Female | 14 (40) | 36 (49.3) | 6 (21.4) | 0.038** |
| Male | 21 (60) | 37 (50.7) | 22 (78.6) | |
| Normal weight | 34 (97.1) | 33 (45.2) | 4 (14.3) | <0.001** |
| Over-weight | 1 (2.9) | 10 (13.7) | 1 (3.6) | |
| Obesity class 1 | 0 (0) | 29 (39.7) | 18 (64.3) | |
| Obesity class 2 | 0 (0) | 1 (1.4) | 5 (17.9) | |
| Obesity class 3 | 0 (0) | 0 (0) | 0 (0) | |
| Vitamin D deficiency | 5 (14.3) | 42 (57.5) | 18 (64.3) | <0.001** |
| Hypercholesterolemia | 0 (0) | 3 (4.1) | 2 (7.1) | 0.313** |
| Hypertriglyceridemia | 0 (0) | 6 (8.2) | 6 (21.4) | 0.011** |
| Steatosis | ||||
| Grade 0 | 35 (100) | 0 (0) | 0 (0) | <0.001** |
| Grade 1 | 0 (0) | 54 (74) | 8 (28.6) | |
| Grade 2 | 0 (0) | 15 (20.5) | 17 (60.7) | |
| Grade 3 | 0 (0) | 4 (5.5) | 3 (10.7) | |